{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":null,"value":72},{"name":null,"value":26},{"name":null,"value":40},{"name":null,"value":27},{"name":null,"value":80},{"name":null,"value":28},{"name":null,"value":35},{"name":null,"value":10},{"name":null,"value":134},{"name":null,"value":121},{"name":null,"value":78},{"name":null,"value":29},{"name":null,"value":32},{"name":null,"value":31},{"name":null,"value":33},{"name":null,"value":126},{"name":"Real Estate","value":36},{"name":null,"value":82},{"name":null,"value":37},{"name":null,"value":115},{"name":"Government Matters","value":"cg-2"},{"name":null,"value":1},{"name":null,"value":6},{"name":null,"value":71},{"name":null,"value":21},{"name":null,"value":23},{"name":null,"value":116},{"name":null,"value":24},{"name":null,"value":135},{"name":null,"value":25},{"name":null,"value":110},{"name":null,"value":20},{"name":null,"value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":null,"value":129},{"name":null,"value":2},{"name":null,"value":38},{"name":null,"value":3},{"name":null,"value":5},{"name":null,"value":19},{"name":null,"value":7},{"name":null,"value":4},{"name":null,"value":136},{"name":null,"value":13},{"name":null,"value":14},{"name":null,"value":15},{"name":null,"value":17},{"name":null,"value":18},{"name":null,"value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":null,"value":133},{"name":null,"value":106},{"name":null,"value":124},{"name":null,"value":111},{"name":null,"value":132},{"name":null,"value":131},{"name":null,"value":102},{"name":null,"value":125},{"name":null,"value":127},{"name":null,"value":107},{"name":null,"value":112},{"name":null,"value":105},{"name":null,"value":109},{"name":null,"value":103},{"name":null,"value":128},{"name":null,"value":123},{"name":null,"value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"32","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"R","per_page":12,"people":[{"id":432953,"version":1,"owner_type":"Person","owner_id":986,"payload":{"bio":"\u003cp\u003eNikki Reeves is an FDA and healthcare regulatory compliance lawyer with more than 25\u0026nbsp;years of experience.\u0026nbsp; Nikki co-chairs the firm's Government Matters \u0026amp; Regulatory practice management group, which is comprised of 200+ lawyers and consultants in eight practice areas.\u0026nbsp; Nikki previously co-chaired\u0026nbsp;the firm\u0026rsquo;s Life Sciences and Healthcare Industry Group for six years, which is comprised of more than 450\u0026nbsp;lawyers across seventeen practice areas in the firm.\u0026nbsp; In 2024, Nikki was a winner of Corporate Counsel's 2024 Women, Influence \u0026amp; Power in Law Award for Law Firm Thought Leadership.\u0026nbsp; Nikki is ranked nationally by \u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;for Life Sciences: Regulatory Compliance and for Pharmaceuticals/Medical Products Regulatory from 2021-2025, named a\u0026nbsp;\u003cem\u003eLMG Life Sciences Star\u003c/em\u003e in FDA Pharmaceutical and in FDA Medical Device from 2019-2025, and was named a\u0026nbsp;\u003cem\u003eLaw360 Compliance MVP\u003c/em\u003e\u0026nbsp;in 2020.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAs Deputy Chair of our FDA \u0026amp; Life Sciences practice, Nikki advises pharmaceutical and medical device companies on pre- and post-market FDA regulatory compliance and enforcement matters ranging from clinical trials, good manufacturing practices, to labeling, advertising, and promotion of FDA-regulated products.\u0026nbsp; Nikki has been the lead FDA regulatory advisor to her clients on 250+ transactional matters.\u0026nbsp; She conducts investigations into FDA clinical trials and post-marking noncompliance, acts as lead compliance and regulatory counsel for several companies under Corporate Integrity Agreements (CIAs) and has led several CMS Open Payments compliance audits.\u0026nbsp; She is an expert on federal Open Payments, state, and international transparency/disclosure laws and leads two pharma and device industry compliance coalitions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNikki counsels pharma and device companies on FDA inspections, Form 483s, Warning Letters, product recalls, import detentions, clinical holds, and other FDA compliance and enforcement matters.\u0026nbsp; She conducts risk assessments and internal investigations into allegations of FDA and healthcare program noncompliance.\u0026nbsp; She routinely advises company executives and board members and represents her clients before federal agencies.\u0026nbsp; She has established robust compliance programs and policies for numerous life sciences companies. Nikki has also served as an interim General Counsel and as a Chief Compliance Officer for her life sciences clients.\u003c/p\u003e\n\u003cp\u003eNikki leads two pharma and device industry coalitions on transparency and disclosure laws.\u0026nbsp; The\u0026nbsp;\u003cem\u003eAd Hoc Sunshine and State Law Compliance Group\u003c/em\u003e is a coalition she advises on federal Sunshine Act and state transparency/disclosure and gift ban laws.\u0026nbsp; The \u003cem\u003eInternational Marketing and Disclosure Compliance Group\u003c/em\u003e is a separate coalition of companies she advises on the growing area of transparency and disclosure laws and industry codes of conduct in the EU, Australia, Japan, and numerous other countries and regions.\u003c/p\u003e\n\u003cp\u003eKing \u0026amp; Spalding\u0026rsquo;s FDA \u0026amp; Life Sciences Practice has been named \u003cem\u003eLaw360\u003c/em\u003e Practice Group of the Year from 2017-2020.\u0026nbsp; King \u0026amp; Spalding\u0026rsquo;s FDA \u0026amp; Life Sciences Practice is ranked by Chambers Legal, LMG Life Sciences, U.S. News, and Best Lawyers.\u0026nbsp; According to\u0026nbsp;\u003cem\u003eChambers USA, sources praise Nikki as being \"thoughtful, quick to respond and available.\" -- Chambers USA\u003c/em\u003e\u0026nbsp;(2022)\u003c/p\u003e\n\u003cp\u003eNikki is a frequent speaker and author on FDA advertising/promotion, clinical trials, compliance, and transparency law matters.\u0026nbsp; Nikki was also selected to Law360's 2021 Compliance Editorial Advisory Board\u0026nbsp;and has served\u0026nbsp;on the\u0026nbsp;Advisory Board for FDAnews and the PCF Pharma Congress planning committee.\u0026nbsp; She was formerly on the Food and Drug Law Institute (FDLI) Editorial Advisory Board for the \u003cem\u003eFDLI Food \u0026amp; Drug Law Journal\u003c/em\u003e and a member of the FDLI Medical Device Committee.\u0026nbsp; Nikki has also served on the Leadership Advisory Board for the National Women\u0026rsquo;s Law Center and on the Special Gifts Committee for the Arlington Free Clinic for more than ten\u0026nbsp;years.\u003c/p\u003e\n\u003cp\u003eNikki was elected by her partners in 2017 to serve for three years\u0026nbsp;on the firm\u0026rsquo;s Policy Committee, which is the firm's executive management committee.\u0026nbsp; Nikki served for many years on the firm\u0026rsquo;s Lateral Partner Committee and on the firm's Partners Committee, and was also the Hiring Partner for the Washington, D.C. office.\u003c/p\u003e","slug":"nikki-reeves","email":"nreeves@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvised companies on FDA advertising and promotion rules for drugs, devices, and cosmetics, including social media, new product launches, DTC, physician and payor communications, broadcast ads, reprints, and investor communications.\u003c/p\u003e","\u003cp\u003eAdvised on CMS Open Payments compliance audits and compliance with the federal Physician Payment Sunshine (Open Payments) law, state laws targeting industry marketing practices, sales representation licensing, drug price transparency, and disclosure of clinical trial data. Advised on compliance with global transparency laws and industry codes of conduct.\u003c/p\u003e","\u003cp\u003eAdvised life sciences clients on preparing for FDA inspections of clinical trials sites and manufacturing facilities, and responding to FDA Form 483s, FDA Warning Letters, product recalls, import detentions, and government investigations involving alleged advertising/promotion violations.\u003c/p\u003e","\u003cp\u003eConducted FDA regulatory due diligence and related counseling in connection with more than 200+ transactions involving pharmaceutical, medical device, biotechnology, and cosmetic companies.\u003c/p\u003e","\u003cp\u003eStand up healthcare compliance programs for pharmaceutical and medical device manufacturers and related healthcare compliance policies and codes of conduct. Served as interim Chief Compliance Officer for a pharmaceutical manufacturer for a two year period and managed all aspects of the company healthcare compliance program.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into potential FDA GCP, GMP, and healthcare compliance policy violations.\u003c/p\u003e","\u003cp\u003eLed risk assessments of healthcare regulatory compliance programs and policies and advised on compliance with FDA regulations, HHS OIG Compliance Program Guidance, and the PhRMA and AdvaMed Codes on Interactions with Healthcare Professionals.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":245}]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":761,"guid":"761.smart_tags","index":1,"source":"smartTags"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":23,"guid":"23.capabilities","index":3,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":4,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":7,"source":"capabilities"},{"id":970,"guid":"970.smart_tags","index":8,"source":"smartTags"},{"id":109,"guid":"109.capabilities","index":9,"source":"capabilities"},{"id":112,"guid":"112.capabilities","index":10,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":11,"source":"capabilities"},{"id":120,"guid":"120.capabilities","index":12,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":13,"source":"capabilities"},{"id":1193,"guid":"1193.smart_tags","index":14,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":15,"source":"smartTags"},{"id":135,"guid":"135.capabilities","index":16,"source":"capabilities"}],"is_active":true,"last_name":"Reeves","nick_name":"Nikki","clerkships":[],"first_name":"Nikki","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Women, Influence \u0026 Power in Law Award for Thought Leadership","detail":"Corporate Counsel 2024"}],"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eNikki Reeves is an FDA and healthcare regulatory compliance lawyer with more than 25\u0026nbsp;years of experience.\u0026nbsp; Nikki co-chairs the firm's Government Matters \u0026amp; Regulatory practice management group, which is comprised of 200+ lawyers and consultants in eight practice areas.\u0026nbsp; Nikki previously co-chaired\u0026nbsp;the firm\u0026rsquo;s Life Sciences and Healthcare Industry Group for six years, which is comprised of more than 450\u0026nbsp;lawyers across seventeen practice areas in the firm.\u0026nbsp; In 2024, Nikki was a winner of Corporate Counsel's 2024 Women, Influence \u0026amp; Power in Law Award for Law Firm Thought Leadership.\u0026nbsp; Nikki is ranked nationally by \u003cem\u003eChambers USA\u003c/em\u003e\u0026nbsp;for Life Sciences: Regulatory Compliance and for Pharmaceuticals/Medical Products Regulatory from 2021-2025, named a\u0026nbsp;\u003cem\u003eLMG Life Sciences Star\u003c/em\u003e in FDA Pharmaceutical and in FDA Medical Device from 2019-2025, and was named a\u0026nbsp;\u003cem\u003eLaw360 Compliance MVP\u003c/em\u003e\u0026nbsp;in 2020.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAs Deputy Chair of our FDA \u0026amp; Life Sciences practice, Nikki advises pharmaceutical and medical device companies on pre- and post-market FDA regulatory compliance and enforcement matters ranging from clinical trials, good manufacturing practices, to labeling, advertising, and promotion of FDA-regulated products.\u0026nbsp; Nikki has been the lead FDA regulatory advisor to her clients on 250+ transactional matters.\u0026nbsp; She conducts investigations into FDA clinical trials and post-marking noncompliance, acts as lead compliance and regulatory counsel for several companies under Corporate Integrity Agreements (CIAs) and has led several CMS Open Payments compliance audits.\u0026nbsp; She is an expert on federal Open Payments, state, and international transparency/disclosure laws and leads two pharma and device industry compliance coalitions.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eNikki counsels pharma and device companies on FDA inspections, Form 483s, Warning Letters, product recalls, import detentions, clinical holds, and other FDA compliance and enforcement matters.\u0026nbsp; She conducts risk assessments and internal investigations into allegations of FDA and healthcare program noncompliance.\u0026nbsp; She routinely advises company executives and board members and represents her clients before federal agencies.\u0026nbsp; She has established robust compliance programs and policies for numerous life sciences companies. Nikki has also served as an interim General Counsel and as a Chief Compliance Officer for her life sciences clients.\u003c/p\u003e\n\u003cp\u003eNikki leads two pharma and device industry coalitions on transparency and disclosure laws.\u0026nbsp; The\u0026nbsp;\u003cem\u003eAd Hoc Sunshine and State Law Compliance Group\u003c/em\u003e is a coalition she advises on federal Sunshine Act and state transparency/disclosure and gift ban laws.\u0026nbsp; The \u003cem\u003eInternational Marketing and Disclosure Compliance Group\u003c/em\u003e is a separate coalition of companies she advises on the growing area of transparency and disclosure laws and industry codes of conduct in the EU, Australia, Japan, and numerous other countries and regions.\u003c/p\u003e\n\u003cp\u003eKing \u0026amp; Spalding\u0026rsquo;s FDA \u0026amp; Life Sciences Practice has been named \u003cem\u003eLaw360\u003c/em\u003e Practice Group of the Year from 2017-2020.\u0026nbsp; King \u0026amp; Spalding\u0026rsquo;s FDA \u0026amp; Life Sciences Practice is ranked by Chambers Legal, LMG Life Sciences, U.S. News, and Best Lawyers.\u0026nbsp; According to\u0026nbsp;\u003cem\u003eChambers USA, sources praise Nikki as being \"thoughtful, quick to respond and available.\" -- Chambers USA\u003c/em\u003e\u0026nbsp;(2022)\u003c/p\u003e\n\u003cp\u003eNikki is a frequent speaker and author on FDA advertising/promotion, clinical trials, compliance, and transparency law matters.\u0026nbsp; Nikki was also selected to Law360's 2021 Compliance Editorial Advisory Board\u0026nbsp;and has served\u0026nbsp;on the\u0026nbsp;Advisory Board for FDAnews and the PCF Pharma Congress planning committee.\u0026nbsp; She was formerly on the Food and Drug Law Institute (FDLI) Editorial Advisory Board for the \u003cem\u003eFDLI Food \u0026amp; Drug Law Journal\u003c/em\u003e and a member of the FDLI Medical Device Committee.\u0026nbsp; Nikki has also served on the Leadership Advisory Board for the National Women\u0026rsquo;s Law Center and on the Special Gifts Committee for the Arlington Free Clinic for more than ten\u0026nbsp;years.\u003c/p\u003e\n\u003cp\u003eNikki was elected by her partners in 2017 to serve for three years\u0026nbsp;on the firm\u0026rsquo;s Policy Committee, which is the firm's executive management committee.\u0026nbsp; Nikki served for many years on the firm\u0026rsquo;s Lateral Partner Committee and on the firm's Partners Committee, and was also the Hiring Partner for the Washington, D.C. office.\u003c/p\u003e","matters":["\u003cp\u003eAdvised companies on FDA advertising and promotion rules for drugs, devices, and cosmetics, including social media, new product launches, DTC, physician and payor communications, broadcast ads, reprints, and investor communications.\u003c/p\u003e","\u003cp\u003eAdvised on CMS Open Payments compliance audits and compliance with the federal Physician Payment Sunshine (Open Payments) law, state laws targeting industry marketing practices, sales representation licensing, drug price transparency, and disclosure of clinical trial data. Advised on compliance with global transparency laws and industry codes of conduct.\u003c/p\u003e","\u003cp\u003eAdvised life sciences clients on preparing for FDA inspections of clinical trials sites and manufacturing facilities, and responding to FDA Form 483s, FDA Warning Letters, product recalls, import detentions, and government investigations involving alleged advertising/promotion violations.\u003c/p\u003e","\u003cp\u003eConducted FDA regulatory due diligence and related counseling in connection with more than 200+ transactions involving pharmaceutical, medical device, biotechnology, and cosmetic companies.\u003c/p\u003e","\u003cp\u003eStand up healthcare compliance programs for pharmaceutical and medical device manufacturers and related healthcare compliance policies and codes of conduct. Served as interim Chief Compliance Officer for a pharmaceutical manufacturer for a two year period and managed all aspects of the company healthcare compliance program.\u003c/p\u003e","\u003cp\u003eConducted internal investigations into potential FDA GCP, GMP, and healthcare compliance policy violations.\u003c/p\u003e","\u003cp\u003eLed risk assessments of healthcare regulatory compliance programs and policies and advised on compliance with FDA regulations, HHS OIG Compliance Program Guidance, and the PhRMA and AdvaMed Codes on Interactions with Healthcare Professionals.\u003c/p\u003e"],"recognitions":[{"title":"Women, Influence \u0026 Power in Law Award for Thought Leadership","detail":"Corporate Counsel 2024"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":1139}]},"capability_group_id":2},"created_at":"2025-07-29T16:08:40.000Z","updated_at":"2025-07-29T16:08:40.000Z","searchable_text":"Reeves{{ FIELD }}{:title=\u0026gt;\"Women, Influence \u0026amp; Power in Law Award for Thought Leadership\", :detail=\u0026gt;\"Corporate Counsel 2024\"}{{ FIELD }}Advised companies on FDA advertising and promotion rules for drugs, devices, and cosmetics, including social media, new product launches, DTC, physician and payor communications, broadcast ads, reprints, and investor communications.{{ FIELD }}Advised on CMS Open Payments compliance audits and compliance with the federal Physician Payment Sunshine (Open Payments) law, state laws targeting industry marketing practices, sales representation licensing, drug price transparency, and disclosure of clinical trial data. Advised on compliance with global transparency laws and industry codes of conduct.{{ FIELD }}Advised life sciences clients on preparing for FDA inspections of clinical trials sites and manufacturing facilities, and responding to FDA Form 483s, FDA Warning Letters, product recalls, import detentions, and government investigations involving alleged advertising/promotion violations.{{ FIELD }}Conducted FDA regulatory due diligence and related counseling in connection with more than 200+ transactions involving pharmaceutical, medical device, biotechnology, and cosmetic companies.{{ FIELD }}Stand up healthcare compliance programs for pharmaceutical and medical device manufacturers and related healthcare compliance policies and codes of conduct. Served as interim Chief Compliance Officer for a pharmaceutical manufacturer for a two year period and managed all aspects of the company healthcare compliance program.{{ FIELD }}Conducted internal investigations into potential FDA GCP, GMP, and healthcare compliance policy violations.{{ FIELD }}Led risk assessments of healthcare regulatory compliance programs and policies and advised on compliance with FDA regulations, HHS OIG Compliance Program Guidance, and the PhRMA and AdvaMed Codes on Interactions with Healthcare Professionals.{{ FIELD }}Nikki Reeves is an FDA and healthcare regulatory compliance lawyer with more than 25 years of experience.  Nikki co-chairs the firm's Government Matters \u0026amp; Regulatory practice management group, which is comprised of 200+ lawyers and consultants in eight practice areas.  Nikki previously co-chaired the firm’s Life Sciences and Healthcare Industry Group for six years, which is comprised of more than 450 lawyers across seventeen practice areas in the firm.  In 2024, Nikki was a winner of Corporate Counsel's 2024 Women, Influence \u0026amp; Power in Law Award for Law Firm Thought Leadership.  Nikki is ranked nationally by Chambers USA for Life Sciences: Regulatory Compliance and for Pharmaceuticals/Medical Products Regulatory from 2021-2025, named a LMG Life Sciences Star in FDA Pharmaceutical and in FDA Medical Device from 2019-2025, and was named a Law360 Compliance MVP in 2020. \nAs Deputy Chair of our FDA \u0026amp; Life Sciences practice, Nikki advises pharmaceutical and medical device companies on pre- and post-market FDA regulatory compliance and enforcement matters ranging from clinical trials, good manufacturing practices, to labeling, advertising, and promotion of FDA-regulated products.  Nikki has been the lead FDA regulatory advisor to her clients on 250+ transactional matters.  She conducts investigations into FDA clinical trials and post-marking noncompliance, acts as lead compliance and regulatory counsel for several companies under Corporate Integrity Agreements (CIAs) and has led several CMS Open Payments compliance audits.  She is an expert on federal Open Payments, state, and international transparency/disclosure laws and leads two pharma and device industry compliance coalitions. \nNikki counsels pharma and device companies on FDA inspections, Form 483s, Warning Letters, product recalls, import detentions, clinical holds, and other FDA compliance and enforcement matters.  She conducts risk assessments and internal investigations into allegations of FDA and healthcare program noncompliance.  She routinely advises company executives and board members and represents her clients before federal agencies.  She has established robust compliance programs and policies for numerous life sciences companies. Nikki has also served as an interim General Counsel and as a Chief Compliance Officer for her life sciences clients.\nNikki leads two pharma and device industry coalitions on transparency and disclosure laws.  The Ad Hoc Sunshine and State Law Compliance Group is a coalition she advises on federal Sunshine Act and state transparency/disclosure and gift ban laws.  The International Marketing and Disclosure Compliance Group is a separate coalition of companies she advises on the growing area of transparency and disclosure laws and industry codes of conduct in the EU, Australia, Japan, and numerous other countries and regions.\nKing \u0026amp; Spalding’s FDA \u0026amp; Life Sciences Practice has been named Law360 Practice Group of the Year from 2017-2020.  King \u0026amp; Spalding’s FDA \u0026amp; Life Sciences Practice is ranked by Chambers Legal, LMG Life Sciences, U.S. News, and Best Lawyers.  According to Chambers USA, sources praise Nikki as being \"thoughtful, quick to respond and available.\" -- Chambers USA (2022)\nNikki is a frequent speaker and author on FDA advertising/promotion, clinical trials, compliance, and transparency law matters.  Nikki was also selected to Law360's 2021 Compliance Editorial Advisory Board and has served on the Advisory Board for FDAnews and the PCF Pharma Congress planning committee.  She was formerly on the Food and Drug Law Institute (FDLI) Editorial Advisory Board for the FDLI Food \u0026amp; Drug Law Journal and a member of the FDLI Medical Device Committee.  Nikki has also served on the Leadership Advisory Board for the National Women’s Law Center and on the Special Gifts Committee for the Arlington Free Clinic for more than ten years.\nNikki was elected by her partners in 2017 to serve for three years on the firm’s Policy Committee, which is the firm's executive management committee.  Nikki served for many years on the firm’s Lateral Partner Committee and on the firm's Partners Committee, and was also the Hiring Partner for the Washington, D.C. office. Kelly Reeves Partner Women, Influence \u0026amp; Power in Law Award for Thought Leadership Corporate Counsel 2024 North Carolina State University  University of Maryland  North Carolina State University  District of Columbia Maryland Advised companies on FDA advertising and promotion rules for drugs, devices, and cosmetics, including social media, new product launches, DTC, physician and payor communications, broadcast ads, reprints, and investor communications. Advised on CMS Open Payments compliance audits and compliance with the federal Physician Payment Sunshine (Open Payments) law, state laws targeting industry marketing practices, sales representation licensing, drug price transparency, and disclosure of clinical trial data. Advised on compliance with global transparency laws and industry codes of conduct. Advised life sciences clients on preparing for FDA inspections of clinical trials sites and manufacturing facilities, and responding to FDA Form 483s, FDA Warning Letters, product recalls, import detentions, and government investigations involving alleged advertising/promotion violations. Conducted FDA regulatory due diligence and related counseling in connection with more than 200+ transactions involving pharmaceutical, medical device, biotechnology, and cosmetic companies. Stand up healthcare compliance programs for pharmaceutical and medical device manufacturers and related healthcare compliance policies and codes of conduct. Served as interim Chief Compliance Officer for a pharmaceutical manufacturer for a two year period and managed all aspects of the company healthcare compliance program. Conducted internal investigations into potential FDA GCP, GMP, and healthcare compliance policy violations. Led risk assessments of healthcare regulatory compliance programs and policies and advised on compliance with FDA regulations, HHS OIG Compliance Program Guidance, and the PhRMA and AdvaMed Codes on Interactions with Healthcare Professionals.","searchable_name":"Nikki Reeves","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":426313,"version":1,"owner_type":"Person","owner_id":2422,"payload":{"bio":"\u003cp\u003eAdam Robison focuses on a wide range of matters involving healthcare providers and suppliers. A partner in our Healthcare practice, Adam represents healthcare clients in a variety of regulatory and transactional matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam represents public and private hospital systems, academic medical centers, medical schools, children's hospitals, hospices, laboratories, physicians and suppliers in various regulatory and transactional matters.\u003c/p\u003e\n\u003cp\u003eAdam counsels clients concerning False Claims Act and Civil Monetary Penalty investigations, fraud and abuse, along with anti-kickback and physician self-referral issues, including physician contracting. He has also worked with clients on Medicare and Medicaid administrative overpayment appeals; Medicare and Medicaid self-disclosures; and compliance with the 60-day overpayment rule; as well as on Medicaid supplemental payment and 1115 Waiver programs.\u003c/p\u003e\n\u003cp\u003eIn addition, Adam advises clients on a variety of transactional matters, including hospital joint operating company agreements, merger and acquisition agreements, and academic affiliation agreements.\u003c/p\u003e","slug":"adam-robison","email":"arobison@kslaw.com","phone":"+1-832-714-8015","matters":["\u003cp\u003eLitigation/Administrative Appeals\u003cbr /\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea large healthcare company\u003c/strong\u003e in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea drug testing laboratory\u003c/strong\u003e in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean oncologist\u003c/strong\u003e before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea coalition of children\u0026rsquo;s hospitals\u003c/strong\u003e in connection with dispute involving cost-settling certain Medicaid primary care case management payments resulting in multimillion-dollar settlements.\u003c/p\u003e","\u003cp\u003eNegotiated a $6 million settlement agreement for \u003cstrong data-redactor-tag=\"strong\"\u003ea children\u0026rsquo;s hospital\u003c/strong\u003e in connection with a dispute involving cost-settling certain Medicaid primary care case management payments.\u003c/p\u003e","\u003cp\u003eFalse Claims Act Matters and Settlements\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea county-owned hospital\u003c/strong\u003e in an approximate $21.75 million settlement of a federal False Claims Act \u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e lawsuit involving allegations of Stark Law and Anti-Kickback Statute violations without a Corporate Integrity Agreement.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea nursing home chain\u003c/strong\u003e in a $4 million settlement of federal and state False Claims Act lawsuit and negotiation of a Corporate Integrity Agreement related to ambulance arrangement allegations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea hospital district\u003c/strong\u003e in a favorable $3.3 million settlement of federal and state False Claims Act lawsuit involving physician billing without a Corporate Integrity Agreement.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea national hospice\u003c/strong\u003e in negotiating an approximate $25 million settlement and negotiated Corporate Integrity Agreement based on allegations of lack of medically necessary services.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea county hospital district\u003c/strong\u003e in negotiating an approximate $15 million settlement and negotiated corporate compliance agreement related to allegations of lack of Medicare Secondary Payer issues and claims for prisoners.\u003c/p\u003e","\u003cp\u003eTransactions\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea medical school\u003c/strong\u003e in negotiating $100 plus million joint operating company and physician clinically integrated network agreements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea medical school\u003c/strong\u003e in the annual negotiation of $220 plus million physician coverage and academic affiliation agreements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state university/academic medical center\u003c/strong\u003e in the successful negotiation of a $338 million agreement with the state\u0026rsquo;s department of criminal justice for the provision of correctional healthcare services to state inmates.\u003c/p\u003e","\u003cp\u003eHealth Regulatory and Self-Disclosures\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state medical school\u003c/strong\u003e in obtaining provider-based on-campus designation for its $66 million radiation oncology facility resulting in millions of dollars of additional reimbursement per year.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state medical school\u003c/strong\u003e in obtaining a favorable advisory opinion from the Office of Inspector General related to the medical school\u0026rsquo;s prenatal care programs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean academic medical center hospital\u003c/strong\u003e in obtaining retroactive listing as a covered entity under the 340B drug discount program, resulting in $4.5 plus million in drug savings.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003emultiple hospital systems and providers\u003c/strong\u003e in self-disclosing overpayments to Medicare Administrative Contractors, the Office of Inspector General (self-disclosure protocol) and various state Medicaid agencies.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003evarious participants\u003c/strong\u003e regarding the development and implementation of Medicaid supplemental payment/1115 Waiver programs to provide enhanced Medicaid payments to hospitals and other providers located in multiple counties in Texas.\u003c/p\u003e","\u003cp\u003eReviewed and analyzed physician and referral arrangements on behalf of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple financial institutions\u003c/strong\u003e in connection with hospital public finance transactions to determine compliance with the Anti-Kickback Statute and Stark Law.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea multi-hospital system\u003c/strong\u003e in voluntarily disclosing pursuant to the OIG through the OIG Self-Disclosure Protocol its employment of individuals excluded from participation in federal healthcare programs.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":6,"guid":"6.capabilities","index":0,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":4,"source":"capabilities"},{"id":24,"guid":"24.capabilities","index":5,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":6,"source":"smartTags"},{"id":952,"guid":"952.smart_tags","index":7,"source":"smartTags"},{"id":114,"guid":"114.capabilities","index":8,"source":"capabilities"}],"is_active":true,"last_name":"Robison","nick_name":"Adam","clerkships":[],"first_name":"Adam","title_rank":9999,"updated_by":101,"law_schools":[],"middle_name":" ","name_suffix":"","recognitions":[{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas (2019-2022)"},{"title":"\"Adam Robison has a very deep understanding of the specificities of healthcare transactions.\"","detail":"Chambers USA (2022)"},{"title":"Healthcare Super Lawyer: Texas","detail":"Super Lawyers, 2013–2016"},{"title":"Rising Star: Texas","detail":"Super Lawyers, 2010–2012"}],"linked_in_url":"https://www.linkedin.com/in/adam-robison-03538125/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAdam Robison focuses on a wide range of matters involving healthcare providers and suppliers. A partner in our Healthcare practice, Adam represents healthcare clients in a variety of regulatory and transactional matters.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAdam represents public and private hospital systems, academic medical centers, medical schools, children's hospitals, hospices, laboratories, physicians and suppliers in various regulatory and transactional matters.\u003c/p\u003e\n\u003cp\u003eAdam counsels clients concerning False Claims Act and Civil Monetary Penalty investigations, fraud and abuse, along with anti-kickback and physician self-referral issues, including physician contracting. He has also worked with clients on Medicare and Medicaid administrative overpayment appeals; Medicare and Medicaid self-disclosures; and compliance with the 60-day overpayment rule; as well as on Medicaid supplemental payment and 1115 Waiver programs.\u003c/p\u003e\n\u003cp\u003eIn addition, Adam advises clients on a variety of transactional matters, including hospital joint operating company agreements, merger and acquisition agreements, and academic affiliation agreements.\u003c/p\u003e","matters":["\u003cp\u003eLitigation/Administrative Appeals\u003cbr /\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea large healthcare company\u003c/strong\u003e in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea drug testing laboratory\u003c/strong\u003e in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean oncologist\u003c/strong\u003e before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.\u003c/p\u003e","\u003cp\u003eSuccessfully represented \u003cstrong data-redactor-tag=\"strong\"\u003ea coalition of children\u0026rsquo;s hospitals\u003c/strong\u003e in connection with dispute involving cost-settling certain Medicaid primary care case management payments resulting in multimillion-dollar settlements.\u003c/p\u003e","\u003cp\u003eNegotiated a $6 million settlement agreement for \u003cstrong data-redactor-tag=\"strong\"\u003ea children\u0026rsquo;s hospital\u003c/strong\u003e in connection with a dispute involving cost-settling certain Medicaid primary care case management payments.\u003c/p\u003e","\u003cp\u003eFalse Claims Act Matters and Settlements\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea county-owned hospital\u003c/strong\u003e in an approximate $21.75 million settlement of a federal False Claims Act \u003cem data-redactor-tag=\"em\"\u003equi tam\u003c/em\u003e lawsuit involving allegations of Stark Law and Anti-Kickback Statute violations without a Corporate Integrity Agreement.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea nursing home chain\u003c/strong\u003e in a $4 million settlement of federal and state False Claims Act lawsuit and negotiation of a Corporate Integrity Agreement related to ambulance arrangement allegations.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea hospital district\u003c/strong\u003e in a favorable $3.3 million settlement of federal and state False Claims Act lawsuit involving physician billing without a Corporate Integrity Agreement.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea national hospice\u003c/strong\u003e in negotiating an approximate $25 million settlement and negotiated Corporate Integrity Agreement based on allegations of lack of medically necessary services.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea county hospital district\u003c/strong\u003e in negotiating an approximate $15 million settlement and negotiated corporate compliance agreement related to allegations of lack of Medicare Secondary Payer issues and claims for prisoners.\u003c/p\u003e","\u003cp\u003eTransactions\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea medical school\u003c/strong\u003e in negotiating $100 plus million joint operating company and physician clinically integrated network agreements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea medical school\u003c/strong\u003e in the annual negotiation of $220 plus million physician coverage and academic affiliation agreements.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state university/academic medical center\u003c/strong\u003e in the successful negotiation of a $338 million agreement with the state\u0026rsquo;s department of criminal justice for the provision of correctional healthcare services to state inmates.\u003c/p\u003e","\u003cp\u003eHealth Regulatory and Self-Disclosures\u003cbr /\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state medical school\u003c/strong\u003e in obtaining provider-based on-campus designation for its $66 million radiation oncology facility resulting in millions of dollars of additional reimbursement per year.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea state medical school\u003c/strong\u003e in obtaining a favorable advisory opinion from the Office of Inspector General related to the medical school\u0026rsquo;s prenatal care programs.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ean academic medical center hospital\u003c/strong\u003e in obtaining retroactive listing as a covered entity under the 340B drug discount program, resulting in $4.5 plus million in drug savings.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003emultiple hospital systems and providers\u003c/strong\u003e in self-disclosing overpayments to Medicare Administrative Contractors, the Office of Inspector General (self-disclosure protocol) and various state Medicaid agencies.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003evarious participants\u003c/strong\u003e regarding the development and implementation of Medicaid supplemental payment/1115 Waiver programs to provide enhanced Medicaid payments to hospitals and other providers located in multiple counties in Texas.\u003c/p\u003e","\u003cp\u003eReviewed and analyzed physician and referral arrangements on behalf of \u003cstrong data-redactor-tag=\"strong\"\u003emultiple financial institutions\u003c/strong\u003e in connection with hospital public finance transactions to determine compliance with the Anti-Kickback Statute and Stark Law.\u003c/p\u003e","\u003cp\u003eRepresented \u003cstrong data-redactor-tag=\"strong\"\u003ea multi-hospital system\u003c/strong\u003e in voluntarily disclosing pursuant to the OIG through the OIG Self-Disclosure Protocol its employment of individuals excluded from participation in federal healthcare programs.\u003c/p\u003e"],"recognitions":[{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas (2019-2022)"},{"title":"\"Adam Robison has a very deep understanding of the specificities of healthcare transactions.\"","detail":"Chambers USA (2022)"},{"title":"Healthcare Super Lawyer: Texas","detail":"Super Lawyers, 2013–2016"},{"title":"Rising Star: Texas","detail":"Super Lawyers, 2010–2012"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":89}]},"capability_group_id":2},"created_at":"2025-05-26T04:50:47.000Z","updated_at":"2025-05-26T04:50:47.000Z","searchable_text":"Robison{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Texas (2019-2022)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Adam Robison has a very deep understanding of the specificities of healthcare transactions.\\\"\", :detail=\u0026gt;\"Chambers USA (2022)\"}{{ FIELD }}{:title=\u0026gt;\"Healthcare Super Lawyer: Texas\", :detail=\u0026gt;\"Super Lawyers, 2013–2016\"}{{ FIELD }}{:title=\u0026gt;\"Rising Star: Texas\", :detail=\u0026gt;\"Super Lawyers, 2010–2012\"}{{ FIELD }}Litigation/Administrative AppealsSuccessfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated.{{ FIELD }}Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction.{{ FIELD }}Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment.{{ FIELD }}Successfully represented a coalition of children’s hospitals in connection with dispute involving cost-settling certain Medicaid primary care case management payments resulting in multimillion-dollar settlements.{{ FIELD }}Negotiated a $6 million settlement agreement for a children’s hospital in connection with a dispute involving cost-settling certain Medicaid primary care case management payments.{{ FIELD }}False Claims Act Matters and SettlementsRepresented a county-owned hospital in an approximate $21.75 million settlement of a federal False Claims Act qui tam lawsuit involving allegations of Stark Law and Anti-Kickback Statute violations without a Corporate Integrity Agreement.{{ FIELD }}Represented a nursing home chain in a $4 million settlement of federal and state False Claims Act lawsuit and negotiation of a Corporate Integrity Agreement related to ambulance arrangement allegations.{{ FIELD }}Represented a hospital district in a favorable $3.3 million settlement of federal and state False Claims Act lawsuit involving physician billing without a Corporate Integrity Agreement.{{ FIELD }}Represented a national hospice in negotiating an approximate $25 million settlement and negotiated Corporate Integrity Agreement based on allegations of lack of medically necessary services.{{ FIELD }}Represented a county hospital district in negotiating an approximate $15 million settlement and negotiated corporate compliance agreement related to allegations of lack of Medicare Secondary Payer issues and claims for prisoners.{{ FIELD }}TransactionsRepresented a medical school in negotiating $100 plus million joint operating company and physician clinically integrated network agreements.{{ FIELD }}Represented a medical school in the annual negotiation of $220 plus million physician coverage and academic affiliation agreements.{{ FIELD }}Represented a state university/academic medical center in the successful negotiation of a $338 million agreement with the state’s department of criminal justice for the provision of correctional healthcare services to state inmates.{{ FIELD }}Health Regulatory and Self-DisclosuresRepresented a state medical school in obtaining provider-based on-campus designation for its $66 million radiation oncology facility resulting in millions of dollars of additional reimbursement per year.{{ FIELD }}Represented a state medical school in obtaining a favorable advisory opinion from the Office of Inspector General related to the medical school’s prenatal care programs.{{ FIELD }}Represented an academic medical center hospital in obtaining retroactive listing as a covered entity under the 340B drug discount program, resulting in $4.5 plus million in drug savings.{{ FIELD }}Represented multiple hospital systems and providers in self-disclosing overpayments to Medicare Administrative Contractors, the Office of Inspector General (self-disclosure protocol) and various state Medicaid agencies.{{ FIELD }}Represented various participants regarding the development and implementation of Medicaid supplemental payment/1115 Waiver programs to provide enhanced Medicaid payments to hospitals and other providers located in multiple counties in Texas.{{ FIELD }}Reviewed and analyzed physician and referral arrangements on behalf of multiple financial institutions in connection with hospital public finance transactions to determine compliance with the Anti-Kickback Statute and Stark Law.{{ FIELD }}Represented a multi-hospital system in voluntarily disclosing pursuant to the OIG through the OIG Self-Disclosure Protocol its employment of individuals excluded from participation in federal healthcare programs.{{ FIELD }}Adam Robison focuses on a wide range of matters involving healthcare providers and suppliers. A partner in our Healthcare practice, Adam represents healthcare clients in a variety of regulatory and transactional matters.\nAdam represents public and private hospital systems, academic medical centers, medical schools, children's hospitals, hospices, laboratories, physicians and suppliers in various regulatory and transactional matters.\nAdam counsels clients concerning False Claims Act and Civil Monetary Penalty investigations, fraud and abuse, along with anti-kickback and physician self-referral issues, including physician contracting. He has also worked with clients on Medicare and Medicaid administrative overpayment appeals; Medicare and Medicaid self-disclosures; and compliance with the 60-day overpayment rule; as well as on Medicaid supplemental payment and 1115 Waiver programs.\nIn addition, Adam advises clients on a variety of transactional matters, including hospital joint operating company agreements, merger and acquisition agreements, and academic affiliation agreements. Partner Top Ranked Lawyer, Healthcare Chambers USA, Texas (2019-2022) \"Adam Robison has a very deep understanding of the specificities of healthcare transactions.\" Chambers USA (2022) Healthcare Super Lawyer: Texas Super Lawyers, 2013–2016 Rising Star: Texas Super Lawyers, 2010–2012 Brigham Young University J. Reuben Clark Law School South Texas College of Law South Texas College of Law Texas Litigation/Administrative AppealsSuccessfully represented a large healthcare company in obtaining an $18 million arbitration award against the sellers of a hospice pursuant to claims for indemnification and fraud related to a self-disclosure audit that Adam also facilitated. Successfully represented a drug testing laboratory in reducing a $31 million Medicare overpayment resulting in more than a $29 million overpayment reduction. Represented an oncologist before the Administrative Law Judge in a Medicare overpayment case resulting in the full reversal of the alleged multimillion-dollar overpayment. Successfully represented a coalition of children’s hospitals in connection with dispute involving cost-settling certain Medicaid primary care case management payments resulting in multimillion-dollar settlements. Negotiated a $6 million settlement agreement for a children’s hospital in connection with a dispute involving cost-settling certain Medicaid primary care case management payments. False Claims Act Matters and SettlementsRepresented a county-owned hospital in an approximate $21.75 million settlement of a federal False Claims Act qui tam lawsuit involving allegations of Stark Law and Anti-Kickback Statute violations without a Corporate Integrity Agreement. Represented a nursing home chain in a $4 million settlement of federal and state False Claims Act lawsuit and negotiation of a Corporate Integrity Agreement related to ambulance arrangement allegations. Represented a hospital district in a favorable $3.3 million settlement of federal and state False Claims Act lawsuit involving physician billing without a Corporate Integrity Agreement. Represented a national hospice in negotiating an approximate $25 million settlement and negotiated Corporate Integrity Agreement based on allegations of lack of medically necessary services. Represented a county hospital district in negotiating an approximate $15 million settlement and negotiated corporate compliance agreement related to allegations of lack of Medicare Secondary Payer issues and claims for prisoners. TransactionsRepresented a medical school in negotiating $100 plus million joint operating company and physician clinically integrated network agreements. Represented a medical school in the annual negotiation of $220 plus million physician coverage and academic affiliation agreements. Represented a state university/academic medical center in the successful negotiation of a $338 million agreement with the state’s department of criminal justice for the provision of correctional healthcare services to state inmates. Health Regulatory and Self-DisclosuresRepresented a state medical school in obtaining provider-based on-campus designation for its $66 million radiation oncology facility resulting in millions of dollars of additional reimbursement per year. Represented a state medical school in obtaining a favorable advisory opinion from the Office of Inspector General related to the medical school’s prenatal care programs. Represented an academic medical center hospital in obtaining retroactive listing as a covered entity under the 340B drug discount program, resulting in $4.5 plus million in drug savings. Represented multiple hospital systems and providers in self-disclosing overpayments to Medicare Administrative Contractors, the Office of Inspector General (self-disclosure protocol) and various state Medicaid agencies. Represented various participants regarding the development and implementation of Medicaid supplemental payment/1115 Waiver programs to provide enhanced Medicaid payments to hospitals and other providers located in multiple counties in Texas. Reviewed and analyzed physician and referral arrangements on behalf of multiple financial institutions in connection with hospital public finance transactions to determine compliance with the Anti-Kickback Statute and Stark Law. Represented a multi-hospital system in voluntarily disclosing pursuant to the OIG through the OIG Self-Disclosure Protocol its employment of individuals excluded from participation in federal healthcare programs.","searchable_name":"Adam Robison","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":101,"capability_group_featured":null,"home_page_featured":null},{"id":443993,"version":1,"owner_type":"Person","owner_id":7083,"payload":{"bio":"\u003cp\u003eWill Rollins is a former federal prosecutor and partner in King \u0026amp; Spalding\u0026rsquo;s Los Angeles office. He focuses on complex commercial litigation and government enforcement and regulatory matters.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs an Assistant U.S. Attorney, Will tried high-profile cases arising out of complex criminal and national security investigations. In addition to his jury trial work, Will briefed and argued appeals before the U.S. Court of Appeals for the Ninth Circuit and led dozens of complex grand jury investigations. Will prosecuted white collar crimes, as well as multiple gang and cartel cases, including a wiretap investigation into a Mexican Mafia-affiliated street gang that resulted in the indictment of 17 defendants. He later joined the National Security Division of the U.S. Attorney\u0026rsquo;s Office, where he focused on counterterrorism and counterintelligence. Will received recognition for exceptional trial and investigative work from the Director of National Intelligence, FBI, IRS, DEA, Secret Service, and Financial Crimes Enforcement Network.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAfter leaving the Department of Justice, Will became the Democratic nominee for the U.S. House of Representatives in California\u0026rsquo;s 41st District, where he was described in Politico as \u0026ldquo;the best candidate in the country\u0026rdquo; and set the record for the most money raised by a congressional challenger in state history (2024). Will was endorsed by the Los Angeles Times and more than 700 former military and national security officials in both parties. He also received support from former President Bill Clinton, the Governor of California, the Attorney General of California, California\u0026rsquo;s former Republican Assembly Leader, and dozens of members of Congress. Will\u0026rsquo;s extensive media experience includes appearances on CNN, MSNBC, and Fox News, and his campaign was regularly covered by the Wall Street Journal, New York Times, and Washington Post.\u003c/p\u003e\n\u003cp\u003eAt his prior firms, Will focused on complex commercial litigation, including tech company ownership disputes and intellectual property, theft of trade secret, fraud, and breach of fiduciary duty cases.\u003c/p\u003e\n\u003cp\u003eWill clerked for the Hon. Jacqueline H. Nguyen on the U.S. Court of Appeals for the Ninth Circuit and the Hon. George H. Wu in the Central District of California. He also previously served as an aide to Governor Arnold Schwarzenegger.\u003c/p\u003e\n\u003cp\u003eWill earned his J.D. from Columbia Law School and his A.B. from Dartmouth College.\u003c/p\u003e","slug":"will-rollins","email":"wrollins@kslaw.com","phone":null,"matters":["\u003cp\u003eRepresented social media platform and founders in action claiming alleged partner was excluded from the company.\u003c/p\u003e","\u003cp\u003eDefended energy company in mass tort and class action litigation seeking damages in excess of $2 billion.\u003c/p\u003e","\u003cp\u003eRepresented tech company in theft of trade secret, fraud, and breach of fiduciary duty case against digital classified advertising platform.\u003c/p\u003e","\u003cp\u003eRepresented honorary film organization in lawsuit over auction house\u0026rsquo;s improper attempt to acquire and sell organization\u0026rsquo;s iconic statuette.\u003c/p\u003e","\u003cp\u003eRepresented departed hedge fund partner in dispute over partner\u0026rsquo;s ongoing investments in the fund.\u003c/p\u003e","\u003cp\u003eRepresented cofounder of private equity firm in dispute over firm\u0026rsquo;s management and control.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, led the government\u0026rsquo;s investigation into 10 Iranian nationals who conspired to launder more than $750,000,000 through the U.S. financial system.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted drug trafficker who conspired with a flight attendant to smuggle millions of dollars\u0026rsquo; worth of cocaine on commercial flights from Los Angeles to New York.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted electrical engineer who exported U.S. missile guidance technology to military subcontractor for the People\u0026rsquo;s Republic of China.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted medical doctor who attempted to conceal the cash proceeds from his sales of opiate prescriptions.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted defendant who defrauded investors across the U.S. and Canada by impersonating major financial institution.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":74,"guid":"74.capabilities","index":0,"source":"capabilities"},{"id":5,"guid":"5.capabilities","index":1,"source":"capabilities"},{"id":129,"guid":"129.capabilities","index":2,"source":"capabilities"},{"id":3,"guid":"3.capabilities","index":3,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":4,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"},{"id":18,"guid":"18.capabilities","index":6,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":7,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":8,"source":"capabilities"},{"id":687,"guid":"687.smart_tags","index":9,"source":"smartTags"},{"id":1248,"guid":"1248.smart_tags","index":10,"source":"smartTags"},{"id":1153,"guid":"1153.smart_tags","index":11,"source":"smartTags"},{"id":1,"guid":"1.capabilities","index":12,"source":"capabilities"}],"is_active":true,"last_name":"Rollins","nick_name":"Will","clerkships":[{"name":"Judicial Clerk, Honorable Jacqueline H. Nguyen, U.S. Court of Appeals for the Ninth Circuit","years_held":"2015 - 2016"},{"name":"Judicial Clerk, Honorable George H. Wu, Central District of California","years_held":"2013 - 2014"}],"first_name":"Will","title_rank":9999,"updated_by":202,"law_schools":[{"id":485,"meta":{"degree":"J.D.","honors":"Harlan Fiske Stone Scholar","is_law_school":"1","graduation_date":"2012-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/will-rollins-14853646/","seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eWill Rollins is a former federal prosecutor and partner in King \u0026amp; Spalding\u0026rsquo;s Los Angeles office. He focuses on complex commercial litigation and government enforcement and regulatory matters.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAs an Assistant U.S. Attorney, Will tried high-profile cases arising out of complex criminal and national security investigations. In addition to his jury trial work, Will briefed and argued appeals before the U.S. Court of Appeals for the Ninth Circuit and led dozens of complex grand jury investigations. Will prosecuted white collar crimes, as well as multiple gang and cartel cases, including a wiretap investigation into a Mexican Mafia-affiliated street gang that resulted in the indictment of 17 defendants. He later joined the National Security Division of the U.S. Attorney\u0026rsquo;s Office, where he focused on counterterrorism and counterintelligence. Will received recognition for exceptional trial and investigative work from the Director of National Intelligence, FBI, IRS, DEA, Secret Service, and Financial Crimes Enforcement Network.\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAfter leaving the Department of Justice, Will became the Democratic nominee for the U.S. House of Representatives in California\u0026rsquo;s 41st District, where he was described in Politico as \u0026ldquo;the best candidate in the country\u0026rdquo; and set the record for the most money raised by a congressional challenger in state history (2024). Will was endorsed by the Los Angeles Times and more than 700 former military and national security officials in both parties. He also received support from former President Bill Clinton, the Governor of California, the Attorney General of California, California\u0026rsquo;s former Republican Assembly Leader, and dozens of members of Congress. Will\u0026rsquo;s extensive media experience includes appearances on CNN, MSNBC, and Fox News, and his campaign was regularly covered by the Wall Street Journal, New York Times, and Washington Post.\u003c/p\u003e\n\u003cp\u003eAt his prior firms, Will focused on complex commercial litigation, including tech company ownership disputes and intellectual property, theft of trade secret, fraud, and breach of fiduciary duty cases.\u003c/p\u003e\n\u003cp\u003eWill clerked for the Hon. Jacqueline H. Nguyen on the U.S. Court of Appeals for the Ninth Circuit and the Hon. George H. Wu in the Central District of California. He also previously served as an aide to Governor Arnold Schwarzenegger.\u003c/p\u003e\n\u003cp\u003eWill earned his J.D. from Columbia Law School and his A.B. from Dartmouth College.\u003c/p\u003e","matters":["\u003cp\u003eRepresented social media platform and founders in action claiming alleged partner was excluded from the company.\u003c/p\u003e","\u003cp\u003eDefended energy company in mass tort and class action litigation seeking damages in excess of $2 billion.\u003c/p\u003e","\u003cp\u003eRepresented tech company in theft of trade secret, fraud, and breach of fiduciary duty case against digital classified advertising platform.\u003c/p\u003e","\u003cp\u003eRepresented honorary film organization in lawsuit over auction house\u0026rsquo;s improper attempt to acquire and sell organization\u0026rsquo;s iconic statuette.\u003c/p\u003e","\u003cp\u003eRepresented departed hedge fund partner in dispute over partner\u0026rsquo;s ongoing investments in the fund.\u003c/p\u003e","\u003cp\u003eRepresented cofounder of private equity firm in dispute over firm\u0026rsquo;s management and control.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, led the government\u0026rsquo;s investigation into 10 Iranian nationals who conspired to launder more than $750,000,000 through the U.S. financial system.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted drug trafficker who conspired with a flight attendant to smuggle millions of dollars\u0026rsquo; worth of cocaine on commercial flights from Los Angeles to New York.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted electrical engineer who exported U.S. missile guidance technology to military subcontractor for the People\u0026rsquo;s Republic of China.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted medical doctor who attempted to conceal the cash proceeds from his sales of opiate prescriptions.\u003c/p\u003e","\u003cp\u003eAs an Assistant U.S. Attorney, tried and convicted defendant who defrauded investors across the U.S. and Canada by impersonating major financial institution.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12757}]},"capability_group_id":3},"created_at":"2025-12-05T05:02:25.000Z","updated_at":"2025-12-05T05:02:25.000Z","searchable_text":"Rollins{{ FIELD }}Represented social media platform and founders in action claiming alleged partner was excluded from the company.{{ FIELD }}Defended energy company in mass tort and class action litigation seeking damages in excess of $2 billion.{{ FIELD }}Represented tech company in theft of trade secret, fraud, and breach of fiduciary duty case against digital classified advertising platform.{{ FIELD }}Represented honorary film organization in lawsuit over auction house’s improper attempt to acquire and sell organization’s iconic statuette.{{ FIELD }}Represented departed hedge fund partner in dispute over partner’s ongoing investments in the fund.{{ FIELD }}Represented cofounder of private equity firm in dispute over firm’s management and control.{{ FIELD }}As an Assistant U.S. Attorney, led the government’s investigation into 10 Iranian nationals who conspired to launder more than $750,000,000 through the U.S. financial system.{{ FIELD }}As an Assistant U.S. Attorney, tried and convicted drug trafficker who conspired with a flight attendant to smuggle millions of dollars’ worth of cocaine on commercial flights from Los Angeles to New York.{{ FIELD }}As an Assistant U.S. Attorney, tried and convicted electrical engineer who exported U.S. missile guidance technology to military subcontractor for the People’s Republic of China.{{ FIELD }}As an Assistant U.S. Attorney, tried and convicted medical doctor who attempted to conceal the cash proceeds from his sales of opiate prescriptions.{{ FIELD }}As an Assistant U.S. Attorney, tried and convicted defendant who defrauded investors across the U.S. and Canada by impersonating major financial institution.{{ FIELD }}Will Rollins is a former federal prosecutor and partner in King \u0026amp; Spalding’s Los Angeles office. He focuses on complex commercial litigation and government enforcement and regulatory matters. \nAs an Assistant U.S. Attorney, Will tried high-profile cases arising out of complex criminal and national security investigations. In addition to his jury trial work, Will briefed and argued appeals before the U.S. Court of Appeals for the Ninth Circuit and led dozens of complex grand jury investigations. Will prosecuted white collar crimes, as well as multiple gang and cartel cases, including a wiretap investigation into a Mexican Mafia-affiliated street gang that resulted in the indictment of 17 defendants. He later joined the National Security Division of the U.S. Attorney’s Office, where he focused on counterterrorism and counterintelligence. Will received recognition for exceptional trial and investigative work from the Director of National Intelligence, FBI, IRS, DEA, Secret Service, and Financial Crimes Enforcement Network.   \nAfter leaving the Department of Justice, Will became the Democratic nominee for the U.S. House of Representatives in California’s 41st District, where he was described in Politico as “the best candidate in the country” and set the record for the most money raised by a congressional challenger in state history (2024). Will was endorsed by the Los Angeles Times and more than 700 former military and national security officials in both parties. He also received support from former President Bill Clinton, the Governor of California, the Attorney General of California, California’s former Republican Assembly Leader, and dozens of members of Congress. Will’s extensive media experience includes appearances on CNN, MSNBC, and Fox News, and his campaign was regularly covered by the Wall Street Journal, New York Times, and Washington Post.\nAt his prior firms, Will focused on complex commercial litigation, including tech company ownership disputes and intellectual property, theft of trade secret, fraud, and breach of fiduciary duty cases.\nWill clerked for the Hon. Jacqueline H. Nguyen on the U.S. Court of Appeals for the Ninth Circuit and the Hon. George H. Wu in the Central District of California. He also previously served as an aide to Governor Arnold Schwarzenegger.\nWill earned his J.D. from Columbia Law School and his A.B. from Dartmouth College. Partner Dartmouth College  Columbia University Columbia University School of Law California California Bar Association Judicial Clerk, Honorable Jacqueline H. Nguyen, U.S. Court of Appeals for the Ninth Circuit Judicial Clerk, Honorable George H. Wu, Central District of California Represented social media platform and founders in action claiming alleged partner was excluded from the company. Defended energy company in mass tort and class action litigation seeking damages in excess of $2 billion. Represented tech company in theft of trade secret, fraud, and breach of fiduciary duty case against digital classified advertising platform. Represented honorary film organization in lawsuit over auction house’s improper attempt to acquire and sell organization’s iconic statuette. Represented departed hedge fund partner in dispute over partner’s ongoing investments in the fund. Represented cofounder of private equity firm in dispute over firm’s management and control. As an Assistant U.S. Attorney, led the government’s investigation into 10 Iranian nationals who conspired to launder more than $750,000,000 through the U.S. financial system. As an Assistant U.S. Attorney, tried and convicted drug trafficker who conspired with a flight attendant to smuggle millions of dollars’ worth of cocaine on commercial flights from Los Angeles to New York. As an Assistant U.S. Attorney, tried and convicted electrical engineer who exported U.S. missile guidance technology to military subcontractor for the People’s Republic of China. As an Assistant U.S. Attorney, tried and convicted medical doctor who attempted to conceal the cash proceeds from his sales of opiate prescriptions. As an Assistant U.S. Attorney, tried and convicted defendant who defrauded investors across the U.S. and Canada by impersonating major financial institution.","searchable_name":"Will Rollins","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445647,"version":1,"owner_type":"Person","owner_id":3646,"payload":{"bio":"\u003cp\u003eKristin Roshelli is a partner in King \u0026amp; Spalding\u0026rsquo;s Houston Healthcare practice. Kristin\u0026rsquo;s practice focuses on corporate and regulatory matters in the healthcare and life sciences industries.\u0026nbsp; She represents a broad range of prominent healthcare and life science\u0026nbsp;clients\u0026nbsp;on mergers and acquisitions, affiliations, general health law questions, and complex corporate governance and contracting matters. She has extensive experience structuring transactions, particularly as to complex arrangements involving health systems, physician practices, and academic medical centers.\u0026nbsp; Kristin has helped establish the legal and operational framework in connection with the startup of three new medical schools and multiple new health systems.\u0026nbsp; She is also a go-to lawyer for\u0026nbsp;leading pharmaceutical,\u0026nbsp;biotech, organ procurement and other large companies for assistance with complex collaboration arrangements with third parties and in establishing and negotiating\u0026nbsp;their supply chain and other key contracts.\u0026nbsp;\u0026nbsp;Her life sciences work often involves advising on product supply and manufacturing agreements, licensing arrangements, commercialization and distribution agreements, specialty pharmacy agreements,\u0026nbsp;research agreements and other complex collaboration arrangements and\u0026nbsp;key service and supply contracts.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShe is Chambers-ranked for healthcare in Texas\u0026nbsp;and has been\u0026nbsp;recognized by \u003cem\u003eLegal 500\u003c/em\u003e as a \u0026ldquo;Recommended Key Lawyer,\u0026rdquo; by \u003cem\u003eTexas\u0026nbsp;Super Lawyers\u003c/em\u003e as a healthcare rising star,\u0026nbsp;and by\u0026nbsp;\u003cem\u003eTexas Lawyers\u003c/em\u003e with an \u0026ldquo;On the Rise Award,\u0026rdquo; which recognizes lawyers under the age of 40 who have wielded influence in their practice areas in Texas and beyond.\u0026nbsp; Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel\u0026rsquo;s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;The Plot Thickens for the Medicare Narrative Requirement,\u0026rdquo; Law360, February 2015\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;When is a Hospital a \u0026lsquo;New Hospital?,\u0026rsquo;\u0026rdquo; Reimbursement Advisor, Vol. 30, No. 4, December 2014\u003c/li\u003e\n\u003c/ul\u003e","slug":"kristin-roshelli","email":"kroshelli@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":3777}]},"expertise":[{"id":24,"guid":"24.capabilities","index":0,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":1,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":2,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":3,"source":"capabilities"},{"id":826,"guid":"826.smart_tags","index":4,"source":"smartTags"},{"id":32,"guid":"32.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Roshelli","nick_name":"Kristin","clerkships":[{"name":"Law Clerk, P. Kevin Castel, U.S. District Court for the Southern District of New York","years_held":"2010-2011"}],"first_name":"Kristin","title_rank":9999,"updated_by":202,"law_schools":[{"id":2724,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":"1","graduation_date":"2010-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"M.","name_suffix":"","recognitions":[{"title":"\"Kristin is very calm and intelligent, and extremely responsive. I always enjoy working with her.\"","detail":"Chambers USA"},{"title":"\"She is extremely knowledgeable, responsive and always able to navigate the most complex matters\"","detail":"Chambers USA"},{"title":"\"Kristin really understands our business well. She doesn't miss anything and is highly responsive.\"","detail":"Chambers USA"},{"title":"On the Rise Award","detail":"Texas Lawyer, 2020"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas (2021-2025)"},{"title":"\"She's very wise with her advice, as well as being detail-oriented and organized.\"","detail":"Chambers USA"}],"linked_in_url":null,"seodescription":"Kristin M. Roshelli is a lawyer of our Government Matters \u0026 Regulation Practice Group. Read more.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eKristin Roshelli is a partner in King \u0026amp; Spalding\u0026rsquo;s Houston Healthcare practice. Kristin\u0026rsquo;s practice focuses on corporate and regulatory matters in the healthcare and life sciences industries.\u0026nbsp; She represents a broad range of prominent healthcare and life science\u0026nbsp;clients\u0026nbsp;on mergers and acquisitions, affiliations, general health law questions, and complex corporate governance and contracting matters. She has extensive experience structuring transactions, particularly as to complex arrangements involving health systems, physician practices, and academic medical centers.\u0026nbsp; Kristin has helped establish the legal and operational framework in connection with the startup of three new medical schools and multiple new health systems.\u0026nbsp; She is also a go-to lawyer for\u0026nbsp;leading pharmaceutical,\u0026nbsp;biotech, organ procurement and other large companies for assistance with complex collaboration arrangements with third parties and in establishing and negotiating\u0026nbsp;their supply chain and other key contracts.\u0026nbsp;\u0026nbsp;Her life sciences work often involves advising on product supply and manufacturing agreements, licensing arrangements, commercialization and distribution agreements, specialty pharmacy agreements,\u0026nbsp;research agreements and other complex collaboration arrangements and\u0026nbsp;key service and supply contracts.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eShe is Chambers-ranked for healthcare in Texas\u0026nbsp;and has been\u0026nbsp;recognized by \u003cem\u003eLegal 500\u003c/em\u003e as a \u0026ldquo;Recommended Key Lawyer,\u0026rdquo; by \u003cem\u003eTexas\u0026nbsp;Super Lawyers\u003c/em\u003e as a healthcare rising star,\u0026nbsp;and by\u0026nbsp;\u003cem\u003eTexas Lawyers\u003c/em\u003e with an \u0026ldquo;On the Rise Award,\u0026rdquo; which recognizes lawyers under the age of 40 who have wielded influence in their practice areas in Texas and beyond.\u0026nbsp; Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel\u0026rsquo;s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003ePublications\u003c/strong\u003e\u003c/p\u003e\n\u003cul\u003e\n\u003cli\u003e2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;The Plot Thickens for the Medicare Narrative Requirement,\u0026rdquo; Law360, February 2015\u003c/li\u003e\n\u003cli\u003e\u0026ldquo;When is a Hospital a \u0026lsquo;New Hospital?,\u0026rsquo;\u0026rdquo; Reimbursement Advisor, Vol. 30, No. 4, December 2014\u003c/li\u003e\n\u003c/ul\u003e","recognitions":[{"title":"\"Kristin is very calm and intelligent, and extremely responsive. I always enjoy working with her.\"","detail":"Chambers USA"},{"title":"\"She is extremely knowledgeable, responsive and always able to navigate the most complex matters\"","detail":"Chambers USA"},{"title":"\"Kristin really understands our business well. She doesn't miss anything and is highly responsive.\"","detail":"Chambers USA"},{"title":"On the Rise Award","detail":"Texas Lawyer, 2020"},{"title":"Top Ranked Lawyer, Healthcare","detail":"Chambers USA, Texas (2021-2025)"},{"title":"\"She's very wise with her advice, as well as being detail-oriented and organized.\"","detail":"Chambers USA"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":11456}]},"capability_group_id":2},"created_at":"2026-02-06T21:25:46.000Z","updated_at":"2026-02-06T21:25:46.000Z","searchable_text":"Roshelli{{ FIELD }}{:title=\u0026gt;\"\\\"Kristin is very calm and intelligent, and extremely responsive. I always enjoy working with her.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"\\\"She is extremely knowledgeable, responsive and always able to navigate the most complex matters\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"\\\"Kristin really understands our business well. She doesn't miss anything and is highly responsive.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}{:title=\u0026gt;\"On the Rise Award\", :detail=\u0026gt;\"Texas Lawyer, 2020\"}{{ FIELD }}{:title=\u0026gt;\"Top Ranked Lawyer, Healthcare\", :detail=\u0026gt;\"Chambers USA, Texas (2021-2025)\"}{{ FIELD }}{:title=\u0026gt;\"\\\"She's very wise with her advice, as well as being detail-oriented and organized.\\\"\", :detail=\u0026gt;\"Chambers USA\"}{{ FIELD }}Kristin Roshelli is a partner in King \u0026amp; Spalding’s Houston Healthcare practice. Kristin’s practice focuses on corporate and regulatory matters in the healthcare and life sciences industries.  She represents a broad range of prominent healthcare and life science clients on mergers and acquisitions, affiliations, general health law questions, and complex corporate governance and contracting matters. She has extensive experience structuring transactions, particularly as to complex arrangements involving health systems, physician practices, and academic medical centers.  Kristin has helped establish the legal and operational framework in connection with the startup of three new medical schools and multiple new health systems.  She is also a go-to lawyer for leading pharmaceutical, biotech, organ procurement and other large companies for assistance with complex collaboration arrangements with third parties and in establishing and negotiating their supply chain and other key contracts.  Her life sciences work often involves advising on product supply and manufacturing agreements, licensing arrangements, commercialization and distribution agreements, specialty pharmacy agreements, research agreements and other complex collaboration arrangements and key service and supply contracts. \nShe is Chambers-ranked for healthcare in Texas and has been recognized by Legal 500 as a “Recommended Key Lawyer,” by Texas Super Lawyers as a healthcare rising star, and by Texas Lawyers with an “On the Rise Award,” which recognizes lawyers under the age of 40 who have wielded influence in their practice areas in Texas and beyond.  Prior to entering the legal field, Kristin served as a nurse in the United States Air Force, worked in the general counsel’s office of a large academic medical center, and practiced as a registered nurse in a medical intensive care unit. \nPublications\n\n2016 Health Care Fraud and Abuse Top Ten List Reimbursement Advisor, Vol 32, No. 6, February 2017\n“The Plot Thickens for the Medicare Narrative Requirement,” Law360, February 2015\n“When is a Hospital a ‘New Hospital?,’” Reimbursement Advisor, Vol. 30, No. 4, December 2014\n Kristin Roshelli lawyer Partner \"Kristin is very calm and intelligent, and extremely responsive. I always enjoy working with her.\" Chambers USA \"She is extremely knowledgeable, responsive and always able to navigate the most complex matters\" Chambers USA \"Kristin really understands our business well. She doesn't miss anything and is highly responsive.\" Chambers USA On the Rise Award Texas Lawyer, 2020 Top Ranked Lawyer, Healthcare Chambers USA, Texas (2021-2025) \"She's very wise with her advice, as well as being detail-oriented and organized.\" Chambers USA University of Pennsylvania University of Pennsylvania Law School St. John's University St. John's University School of Law U.S. District Court for the Eastern District of New York U.S. District Court for the Southern District of New York New Jersey New York Texas American Bar Association (2014) American Health Lawyers Association (2011) New York State Bar Association (2011) Houston Young Lawyers Association (2014) Law Clerk, P. Kevin Castel, U.S. District Court for the Southern District of New York","searchable_name":"Kristin M. Roshelli","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":445577,"version":1,"owner_type":"Person","owner_id":4190,"payload":{"bio":"\u003cp\u003eDavid Runnels maintains a diversified business transactions practice with an emphasis on the renewable energy, conventional energy and real estate industries. As a partner in our corporate practice, David counsels clients in a variety of business transactions. With more than 35\u0026nbsp;years of experience, his representative transactions include various complex asset-based financings, project developments, dispositions and acquisitions. He also has particular experience in business and investment fund formation, business acquisitions, joint ventures, private equity investments, debt restructuring, energy outsourcing and derivative transactions.\u003c/p\u003e","slug":"david-runnels","email":"drunnels@kslaw.com","phone":"+1 713 829 1889","matters":["\u003cp\u003eRepresentation of \u003cstrong\u003eGeneral Motors\u003c/strong\u003e in its relocation from the Renaissance Center to the Hudson\u0026rsquo;s building and related transactions.\u003c/p\u003e","\u003cp\u003eRepresentation of \u003cstrong\u003eLyondellBasell\u003c/strong\u003e in the sale of its ethylene oxide and derivatives business to INEOS Americas.\u003c/p\u003e","\u003cp\u003eAcquisition of the third largest wind farm in the U.S. in 2021.\u003c/p\u003e","\u003cp\u003eGreenfield development of methanol plants in Louisiana and Texas.\u003c/p\u003e","\u003cp\u003eJoint Venture representing an equity investor in a wind farm in development in Oklahoma.\u003c/p\u003e","\u003cp\u003eDisposition of 6 gas fired power plants in California for a private equity client.\u003c/p\u003e","\u003cp\u003eAcquisition of 6 wind farms in New York state for a private equity client.\u003c/p\u003e","\u003cp\u003eDevelopment of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ethe world's largest post-combustion industrial scale carbon capture and sequestration project\u003c/strong\u003e\u0026nbsp;together with an enhanced oil recovery component.\u003c/p\u003e","\u003cp\u003eAcquisitions and dispositions of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eintrastate and interstate pipelines.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresentation of\u0026nbsp;\u003cstrong\u003eequity investors and developers\u003c/strong\u003e\u0026nbsp;in wind and solar energy generation, battery storage and financing transactions across the U.S., including the greenfield development of the largest contracted wind farm in the U.S. in 2012.\u003c/p\u003e","\u003cp\u003eAcquisition and development of\u0026nbsp;\u003cstrong\u003ehealthcare industry business and assets\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eDecommissioning of a gas fired cogeneration power plant.\u003c/p\u003e","\u003cp\u003eAcquisitions and dispositions of\u0026nbsp;\u003cstrong\u003ehealthcare industry businesses and assets\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eDevelopment of natural gas to gasoline and methanol facilities in Louisiana, Texas and Illinois.\u003c/p\u003e","\u003cp\u003eAcquisition of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eone of the largest mortgage loan servicers\u003c/strong\u003e\u0026nbsp;in the U.S.\u003c/p\u003e","\u003cp\u003eRestructuring of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecogeneration facility arrangements,\u003c/strong\u003e\u0026nbsp;including the sale of NOx emissions reduction credits.\u003c/p\u003e","\u003cp\u003eRepresentation of an equity provider\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ein investment in oil and gas properties, including structuring of complex multiparty partnership agreement.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eImplementation and financing of a multiuse integrated office infrastructure project with payments totaling over $4 billion.\u003c/p\u003e","\u003cp\u003eDevelopment and financing of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea mixed use Westin franchised residential\u003c/strong\u003e, hotel and garage using a commercial condominium structure.\u003c/p\u003e","\u003cp\u003eFund formation and domestic and international energy industry acquisitions for investment fund principals.\u003c/p\u003e","\u003cp\u003eNegotiating power purchase agreements, derivatives and renewable energy credit purchases for a retail electric provider.\u003c/p\u003e","\u003cp\u003eTaking\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003erenewable energy collateral\u003c/strong\u003e\u0026nbsp;in securing an energy trading arrangement for an energy investor.\u003c/p\u003e","\u003cp\u003eProject and construction financings of over $6.0 billion.\u003c/p\u003e","\u003cp\u003eRepresentation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eequity providers and developers\u003c/strong\u003e\u0026nbsp;in the hospitality industry.\u003c/p\u003e","\u003cp\u003eFormation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eblind pool equity funds\u003c/strong\u003e\u0026nbsp;for real estate.\u003c/p\u003e","\u003cp\u003eAcquisition of construction industry-related businesses.\u003c/p\u003e","\u003cp\u003eAcquisition of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea currency exchange business.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eSite acquisition and evaluation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emineral rights and entitlements\u003c/strong\u003e\u0026nbsp;for a master planned residential development for a national developer.\u003c/p\u003e","\u003cp\u003eRefinancings of over $3.1 billion in office properties for a national property owner.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eGreenfield development\u003c/strong\u003e\u0026nbsp;of three power plants in midwestern U.S. for a\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eFortune\u003c/em\u003e\u0026nbsp;500 company.\u003c/p\u003e","\u003cp\u003eStructuring\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eincentive-based compensation arrangements\u003c/strong\u003e\u0026nbsp;for portfolio acquisitions for a national investment company.\u003c/p\u003e","\u003cp\u003eRestructuring\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emaster lease and management arrangement\u003c/strong\u003es for office properties covering 900,000 square feet for the property owner.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3493}]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":1,"source":"capabilities"},{"id":35,"guid":"35.capabilities","index":2,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":3,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":4,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":5,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":6,"source":"capabilities"},{"id":36,"guid":"36.capabilities","index":7,"source":"capabilities"},{"id":1166,"guid":"1166.smart_tags","index":8,"source":"smartTags"},{"id":1219,"guid":"1219.smart_tags","index":9,"source":"smartTags"}],"is_active":true,"last_name":"Runnels","nick_name":"David","clerkships":[],"first_name":"David","title_rank":9999,"updated_by":202,"law_schools":[{"id":2055,"meta":{"degree":"J.D.","honors":"honors, Selected to join Texas Law Review","is_law_school":"1","graduation_date":"1986-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"G.","name_suffix":"","recognitions":[{"title":"Recognized as a Stand-out Lawyer","detail":"Thomson Reuters Stand-out Lawyers, 2026"},{"title":"Recognized as a Stand-out Lawyer","detail":"Thomson Reuters Stand-out Lawyers, 2025"},{"title":"Recognized as a Stand-out Lawyer ","detail":"Thomson Reuters Stand-out Lawyers, 2024"},{"title":"Recognized as a Leading Energy Lawyer in The 2024 Lawdragon 500 Leading Energy Lawyers","detail":"Lawdragon, 2024"},{"title":"Recognized as a Best Lawyer 2024 in Corporate Law and Energy Law ","detail":"The Best Lawyers in America, 2024"},{"title":"Recognized as a Best Lawyer 2023 in Corporate Law and Energy Law ","detail":"The Best Lawyers in America, 2023"},{"title":"Recognized as a Super Lawyer 2017 ","detail":"Super Lawyers, 2017"},{"title":"Profiled as a leading Real Estate lawyer ","detail":"Legal 500 US, 2014–2016"},{"title":"Who’s Who in Law, Energy ","detail":"Houston Business Journal, 2015"},{"title":"Rated as AV Preeminent ","detail":"Martindale-Hubbell, 2015"},{"title":"Profiled as a leading Project Finance lawyer ","detail":"Legal 500 US, 2014"},{"title":"Profiled as a leading Renewables and Alternative Energy lawyer ","detail":"Legal 500 US, 2014"},{"title":"Profiled as one of Texas’ Top Rated Lawyers in Real Estate ","detail":"ALM, 2012"}],"linked_in_url":null,"seodescription":"David G. Runnels is a partner of the Corporate Practice Group. Read more about him.","primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eDavid Runnels maintains a diversified business transactions practice with an emphasis on the renewable energy, conventional energy and real estate industries. As a partner in our corporate practice, David counsels clients in a variety of business transactions. With more than 35\u0026nbsp;years of experience, his representative transactions include various complex asset-based financings, project developments, dispositions and acquisitions. He also has particular experience in business and investment fund formation, business acquisitions, joint ventures, private equity investments, debt restructuring, energy outsourcing and derivative transactions.\u003c/p\u003e","matters":["\u003cp\u003eRepresentation of \u003cstrong\u003eGeneral Motors\u003c/strong\u003e in its relocation from the Renaissance Center to the Hudson\u0026rsquo;s building and related transactions.\u003c/p\u003e","\u003cp\u003eRepresentation of \u003cstrong\u003eLyondellBasell\u003c/strong\u003e in the sale of its ethylene oxide and derivatives business to INEOS Americas.\u003c/p\u003e","\u003cp\u003eAcquisition of the third largest wind farm in the U.S. in 2021.\u003c/p\u003e","\u003cp\u003eGreenfield development of methanol plants in Louisiana and Texas.\u003c/p\u003e","\u003cp\u003eJoint Venture representing an equity investor in a wind farm in development in Oklahoma.\u003c/p\u003e","\u003cp\u003eDisposition of 6 gas fired power plants in California for a private equity client.\u003c/p\u003e","\u003cp\u003eAcquisition of 6 wind farms in New York state for a private equity client.\u003c/p\u003e","\u003cp\u003eDevelopment of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ethe world's largest post-combustion industrial scale carbon capture and sequestration project\u003c/strong\u003e\u0026nbsp;together with an enhanced oil recovery component.\u003c/p\u003e","\u003cp\u003eAcquisitions and dispositions of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eintrastate and interstate pipelines.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eRepresentation of\u0026nbsp;\u003cstrong\u003eequity investors and developers\u003c/strong\u003e\u0026nbsp;in wind and solar energy generation, battery storage and financing transactions across the U.S., including the greenfield development of the largest contracted wind farm in the U.S. in 2012.\u003c/p\u003e","\u003cp\u003eAcquisition and development of\u0026nbsp;\u003cstrong\u003ehealthcare industry business and assets\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eDecommissioning of a gas fired cogeneration power plant.\u003c/p\u003e","\u003cp\u003eAcquisitions and dispositions of\u0026nbsp;\u003cstrong\u003ehealthcare industry businesses and assets\u003c/strong\u003e.\u003c/p\u003e","\u003cp\u003eDevelopment of natural gas to gasoline and methanol facilities in Louisiana, Texas and Illinois.\u003c/p\u003e","\u003cp\u003eAcquisition of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eone of the largest mortgage loan servicers\u003c/strong\u003e\u0026nbsp;in the U.S.\u003c/p\u003e","\u003cp\u003eRestructuring of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecogeneration facility arrangements,\u003c/strong\u003e\u0026nbsp;including the sale of NOx emissions reduction credits.\u003c/p\u003e","\u003cp\u003eRepresentation of an equity provider\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ein investment in oil and gas properties, including structuring of complex multiparty partnership agreement.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eImplementation and financing of a multiuse integrated office infrastructure project with payments totaling over $4 billion.\u003c/p\u003e","\u003cp\u003eDevelopment and financing of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea mixed use Westin franchised residential\u003c/strong\u003e, hotel and garage using a commercial condominium structure.\u003c/p\u003e","\u003cp\u003eFund formation and domestic and international energy industry acquisitions for investment fund principals.\u003c/p\u003e","\u003cp\u003eNegotiating power purchase agreements, derivatives and renewable energy credit purchases for a retail electric provider.\u003c/p\u003e","\u003cp\u003eTaking\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003erenewable energy collateral\u003c/strong\u003e\u0026nbsp;in securing an energy trading arrangement for an energy investor.\u003c/p\u003e","\u003cp\u003eProject and construction financings of over $6.0 billion.\u003c/p\u003e","\u003cp\u003eRepresentation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eequity providers and developers\u003c/strong\u003e\u0026nbsp;in the hospitality industry.\u003c/p\u003e","\u003cp\u003eFormation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eblind pool equity funds\u003c/strong\u003e\u0026nbsp;for real estate.\u003c/p\u003e","\u003cp\u003eAcquisition of construction industry-related businesses.\u003c/p\u003e","\u003cp\u003eAcquisition of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ea currency exchange business.\u003c/strong\u003e\u003c/p\u003e","\u003cp\u003eSite acquisition and evaluation of\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emineral rights and entitlements\u003c/strong\u003e\u0026nbsp;for a master planned residential development for a national developer.\u003c/p\u003e","\u003cp\u003eRefinancings of over $3.1 billion in office properties for a national property owner.\u003c/p\u003e","\u003cp\u003e\u003cstrong data-redactor-tag=\"strong\"\u003eGreenfield development\u003c/strong\u003e\u0026nbsp;of three power plants in midwestern U.S. for a\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eFortune\u003c/em\u003e\u0026nbsp;500 company.\u003c/p\u003e","\u003cp\u003eStructuring\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eincentive-based compensation arrangements\u003c/strong\u003e\u0026nbsp;for portfolio acquisitions for a national investment company.\u003c/p\u003e","\u003cp\u003eRestructuring\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003emaster lease and management arrangement\u003c/strong\u003es for office properties covering 900,000 square feet for the property owner.\u003c/p\u003e"],"recognitions":[{"title":"Recognized as a Stand-out Lawyer","detail":"Thomson Reuters Stand-out Lawyers, 2026"},{"title":"Recognized as a Stand-out Lawyer","detail":"Thomson Reuters Stand-out Lawyers, 2025"},{"title":"Recognized as a Stand-out Lawyer ","detail":"Thomson Reuters Stand-out Lawyers, 2024"},{"title":"Recognized as a Leading Energy Lawyer in The 2024 Lawdragon 500 Leading Energy Lawyers","detail":"Lawdragon, 2024"},{"title":"Recognized as a Best Lawyer 2024 in Corporate Law and Energy Law ","detail":"The Best Lawyers in America, 2024"},{"title":"Recognized as a Best Lawyer 2023 in Corporate Law and Energy Law ","detail":"The Best Lawyers in America, 2023"},{"title":"Recognized as a Super Lawyer 2017 ","detail":"Super Lawyers, 2017"},{"title":"Profiled as a leading Real Estate lawyer ","detail":"Legal 500 US, 2014–2016"},{"title":"Who’s Who in Law, Energy ","detail":"Houston Business Journal, 2015"},{"title":"Rated as AV Preeminent ","detail":"Martindale-Hubbell, 2015"},{"title":"Profiled as a leading Project Finance lawyer ","detail":"Legal 500 US, 2014"},{"title":"Profiled as a leading Renewables and Alternative Energy lawyer ","detail":"Legal 500 US, 2014"},{"title":"Profiled as one of Texas’ Top Rated Lawyers in Real Estate ","detail":"ALM, 2012"}]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":5215}]},"capability_group_id":1},"created_at":"2026-02-04T15:57:55.000Z","updated_at":"2026-02-04T15:57:55.000Z","searchable_text":"Runnels{{ FIELD }}{:title=\u0026gt;\"Recognized as a Stand-out Lawyer\", :detail=\u0026gt;\"Thomson Reuters Stand-out Lawyers, 2026\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Stand-out Lawyer\", :detail=\u0026gt;\"Thomson Reuters Stand-out Lawyers, 2025\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Stand-out Lawyer \", :detail=\u0026gt;\"Thomson Reuters Stand-out Lawyers, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Leading Energy Lawyer in The 2024 Lawdragon 500 Leading Energy Lawyers\", :detail=\u0026gt;\"Lawdragon, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Best Lawyer 2024 in Corporate Law and Energy Law \", :detail=\u0026gt;\"The Best Lawyers in America, 2024\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Best Lawyer 2023 in Corporate Law and Energy Law \", :detail=\u0026gt;\"The Best Lawyers in America, 2023\"}{{ FIELD }}{:title=\u0026gt;\"Recognized as a Super Lawyer 2017 \", :detail=\u0026gt;\"Super Lawyers, 2017\"}{{ FIELD }}{:title=\u0026gt;\"Profiled as a leading Real Estate lawyer \", :detail=\u0026gt;\"Legal 500 US, 2014–2016\"}{{ FIELD }}{:title=\u0026gt;\"Who’s Who in Law, Energy \", :detail=\u0026gt;\"Houston Business Journal, 2015\"}{{ FIELD }}{:title=\u0026gt;\"Rated as AV Preeminent \", :detail=\u0026gt;\"Martindale-Hubbell, 2015\"}{{ FIELD }}{:title=\u0026gt;\"Profiled as a leading Project Finance lawyer \", :detail=\u0026gt;\"Legal 500 US, 2014\"}{{ FIELD }}{:title=\u0026gt;\"Profiled as a leading Renewables and Alternative Energy lawyer \", :detail=\u0026gt;\"Legal 500 US, 2014\"}{{ FIELD }}{:title=\u0026gt;\"Profiled as one of Texas’ Top Rated Lawyers in Real Estate \", :detail=\u0026gt;\"ALM, 2012\"}{{ FIELD }}Representation of General Motors in its relocation from the Renaissance Center to the Hudson’s building and related transactions.{{ FIELD }}Representation of LyondellBasell in the sale of its ethylene oxide and derivatives business to INEOS Americas.{{ FIELD }}Acquisition of the third largest wind farm in the U.S. in 2021.{{ FIELD }}Greenfield development of methanol plants in Louisiana and Texas.{{ FIELD }}Joint Venture representing an equity investor in a wind farm in development in Oklahoma.{{ FIELD }}Disposition of 6 gas fired power plants in California for a private equity client.{{ FIELD }}Acquisition of 6 wind farms in New York state for a private equity client.{{ FIELD }}Development of the world's largest post-combustion industrial scale carbon capture and sequestration project together with an enhanced oil recovery component.{{ FIELD }}Acquisitions and dispositions of intrastate and interstate pipelines.{{ FIELD }}Representation of equity investors and developers in wind and solar energy generation, battery storage and financing transactions across the U.S., including the greenfield development of the largest contracted wind farm in the U.S. in 2012.{{ FIELD }}Acquisition and development of healthcare industry business and assets.{{ FIELD }}Decommissioning of a gas fired cogeneration power plant.{{ FIELD }}Acquisitions and dispositions of healthcare industry businesses and assets.{{ FIELD }}Development of natural gas to gasoline and methanol facilities in Louisiana, Texas and Illinois.{{ FIELD }}Acquisition of one of the largest mortgage loan servicers in the U.S.{{ FIELD }}Restructuring of cogeneration facility arrangements, including the sale of NOx emissions reduction credits.{{ FIELD }}Representation of an equity provider in investment in oil and gas properties, including structuring of complex multiparty partnership agreement.{{ FIELD }}Implementation and financing of a multiuse integrated office infrastructure project with payments totaling over $4 billion.{{ FIELD }}Development and financing of a mixed use Westin franchised residential, hotel and garage using a commercial condominium structure.{{ FIELD }}Fund formation and domestic and international energy industry acquisitions for investment fund principals.{{ FIELD }}Negotiating power purchase agreements, derivatives and renewable energy credit purchases for a retail electric provider.{{ FIELD }}Taking renewable energy collateral in securing an energy trading arrangement for an energy investor.{{ FIELD }}Project and construction financings of over $6.0 billion.{{ FIELD }}Representation of equity providers and developers in the hospitality industry.{{ FIELD }}Formation of blind pool equity funds for real estate.{{ FIELD }}Acquisition of construction industry-related businesses.{{ FIELD }}Acquisition of a currency exchange business.{{ FIELD }}Site acquisition and evaluation of mineral rights and entitlements for a master planned residential development for a national developer.{{ FIELD }}Refinancings of over $3.1 billion in office properties for a national property owner.{{ FIELD }}Greenfield development of three power plants in midwestern U.S. for a Fortune 500 company.{{ FIELD }}Structuring incentive-based compensation arrangements for portfolio acquisitions for a national investment company.{{ FIELD }}Restructuring master lease and management arrangements for office properties covering 900,000 square feet for the property owner.{{ FIELD }}David Runnels maintains a diversified business transactions practice with an emphasis on the renewable energy, conventional energy and real estate industries. As a partner in our corporate practice, David counsels clients in a variety of business transactions. With more than 35 years of experience, his representative transactions include various complex asset-based financings, project developments, dispositions and acquisitions. He also has particular experience in business and investment fund formation, business acquisitions, joint ventures, private equity investments, debt restructuring, energy outsourcing and derivative transactions. David Runnels lawyer Partner Recognized as a Stand-out Lawyer Thomson Reuters Stand-out Lawyers, 2026 Recognized as a Stand-out Lawyer Thomson Reuters Stand-out Lawyers, 2025 Recognized as a Stand-out Lawyer  Thomson Reuters Stand-out Lawyers, 2024 Recognized as a Leading Energy Lawyer in The 2024 Lawdragon 500 Leading Energy Lawyers Lawdragon, 2024 Recognized as a Best Lawyer 2024 in Corporate Law and Energy Law  The Best Lawyers in America, 2024 Recognized as a Best Lawyer 2023 in Corporate Law and Energy Law  The Best Lawyers in America, 2023 Recognized as a Super Lawyer 2017  Super Lawyers, 2017 Profiled as a leading Real Estate lawyer  Legal 500 US, 2014–2016 Who’s Who in Law, Energy  Houston Business Journal, 2015 Rated as AV Preeminent  Martindale-Hubbell, 2015 Profiled as a leading Project Finance lawyer  Legal 500 US, 2014 Profiled as a leading Renewables and Alternative Energy lawyer  Legal 500 US, 2014 Profiled as one of Texas’ Top Rated Lawyers in Real Estate  ALM, 2012 The University of Texas at Austin The University of Texas School of Law The University of Texas at Austin The University of Texas School of Law Texas Houston Bar Association Duchesne Academy – Board of Trustees (2006-2012) Post Oak Bank - Advisory Board Member (2005-2019) Texas General Counsel Forum - Board Member (2001-Present) Houston Bar Foundation - Past Board Member and Treasurer Law360 - Energy Editorial Advisory Board Member (2019) Representation of General Motors in its relocation from the Renaissance Center to the Hudson’s building and related transactions. Representation of LyondellBasell in the sale of its ethylene oxide and derivatives business to INEOS Americas. Acquisition of the third largest wind farm in the U.S. in 2021. Greenfield development of methanol plants in Louisiana and Texas. Joint Venture representing an equity investor in a wind farm in development in Oklahoma. Disposition of 6 gas fired power plants in California for a private equity client. Acquisition of 6 wind farms in New York state for a private equity client. Development of the world's largest post-combustion industrial scale carbon capture and sequestration project together with an enhanced oil recovery component. Acquisitions and dispositions of intrastate and interstate pipelines. Representation of equity investors and developers in wind and solar energy generation, battery storage and financing transactions across the U.S., including the greenfield development of the largest contracted wind farm in the U.S. in 2012. Acquisition and development of healthcare industry business and assets. Decommissioning of a gas fired cogeneration power plant. Acquisitions and dispositions of healthcare industry businesses and assets. Development of natural gas to gasoline and methanol facilities in Louisiana, Texas and Illinois. Acquisition of one of the largest mortgage loan servicers in the U.S. Restructuring of cogeneration facility arrangements, including the sale of NOx emissions reduction credits. Representation of an equity provider in investment in oil and gas properties, including structuring of complex multiparty partnership agreement. Implementation and financing of a multiuse integrated office infrastructure project with payments totaling over $4 billion. Development and financing of a mixed use Westin franchised residential, hotel and garage using a commercial condominium structure. Fund formation and domestic and international energy industry acquisitions for investment fund principals. Negotiating power purchase agreements, derivatives and renewable energy credit purchases for a retail electric provider. Taking renewable energy collateral in securing an energy trading arrangement for an energy investor. Project and construction financings of over $6.0 billion. Representation of equity providers and developers in the hospitality industry. Formation of blind pool equity funds for real estate. Acquisition of construction industry-related businesses. Acquisition of a currency exchange business. Site acquisition and evaluation of mineral rights and entitlements for a master planned residential development for a national developer. Refinancings of over $3.1 billion in office properties for a national property owner. Greenfield development of three power plants in midwestern U.S. for a Fortune 500 company. Structuring incentive-based compensation arrangements for portfolio acquisitions for a national investment company. Restructuring master lease and management arrangements for office properties covering 900,000 square feet for the property owner.","searchable_name":"David G. Runnels","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":447655,"version":1,"owner_type":"Person","owner_id":6533,"payload":{"bio":"\u003cp\u003eAngel is an associate in the Atlanta office of King \u0026amp; Spalding and member of the Corporate practice group. Angel's practice focuses on the representation of public and private companies, private equity funds, and strategic corporate investors in a wide range of corporate matters, including mergers and acquisitions and corporate governance. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAngel graduated\u0026nbsp;from\u0026nbsp;the\u0026nbsp;University of Pennsylvania Carey Law School as an\u0026nbsp;inaugural member of the\u0026nbsp;Dr. Sadie T.M. Alexander Scholars Program, a full-tuition\u0026nbsp;merit scholarship. At Penn, she served on the Executive Board of the Black Law Students Association and was a\u0026nbsp;founding member of the Advocacy for Racial and Civil\u0026nbsp;Justice Clinic.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAngel earned her\u0026nbsp;bachelor\u0026rsquo;s degree\u0026nbsp;from Georgetown University, where she double-majored in Sociology and African American Studies.\u003c/p\u003e","slug":"angelica-reed","email":"areed@kslaw.com","phone":"+1 404 229 6975","matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":80,"guid":"80.capabilities","index":3,"source":"capabilities"},{"id":27,"guid":"27.capabilities","index":4,"source":"capabilities"},{"id":126,"guid":"126.capabilities","index":5,"source":"capabilities"},{"id":115,"guid":"115.capabilities","index":6,"source":"capabilities"},{"id":26,"guid":"26.capabilities","index":7,"source":"capabilities"}],"is_active":true,"last_name":"Reed","nick_name":"","clerkships":[],"first_name":"Angel","title_rank":9999,"updated_by":202,"law_schools":[{"id":2282,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2024-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eAngel is an associate in the Atlanta office of King \u0026amp; Spalding and member of the Corporate practice group. Angel's practice focuses on the representation of public and private companies, private equity funds, and strategic corporate investors in a wide range of corporate matters, including mergers and acquisitions and corporate governance. [[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAngel graduated\u0026nbsp;from\u0026nbsp;the\u0026nbsp;University of Pennsylvania Carey Law School as an\u0026nbsp;inaugural member of the\u0026nbsp;Dr. Sadie T.M. Alexander Scholars Program, a full-tuition\u0026nbsp;merit scholarship. At Penn, she served on the Executive Board of the Black Law Students Association and was a\u0026nbsp;founding member of the Advocacy for Racial and Civil\u0026nbsp;Justice Clinic.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAngel earned her\u0026nbsp;bachelor\u0026rsquo;s degree\u0026nbsp;from Georgetown University, where she double-majored in Sociology and African American Studies.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12324}]},"capability_group_id":1},"created_at":"2026-04-20T21:25:21.000Z","updated_at":"2026-04-20T21:25:21.000Z","searchable_text":"Reed{{ FIELD }}Angel is an associate in the Atlanta office of King \u0026amp; Spalding and member of the Corporate practice group. Angel's practice focuses on the representation of public and private companies, private equity funds, and strategic corporate investors in a wide range of corporate matters, including mergers and acquisitions and corporate governance. \nAngel graduated from the University of Pennsylvania Carey Law School as an inaugural member of the Dr. Sadie T.M. Alexander Scholars Program, a full-tuition merit scholarship. At Penn, she served on the Executive Board of the Black Law Students Association and was a founding member of the Advocacy for Racial and Civil Justice Clinic. \nAngel earned her bachelor’s degree from Georgetown University, where she double-majored in Sociology and African American Studies. Associate Georgetown University  University of Pennsylvania University of Pennsylvania Law School Georgia Georgia Bar Association","searchable_name":"Angel Reed","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427253,"version":1,"owner_type":"Person","owner_id":6557,"payload":{"bio":"\u003cp\u003eMichael Regan is an associate in the Corporate practice group. He advises public and private companies, private equity firms and financial institutions on a variety of corporate matters, including mergers, acquisitions, investments and joint ventures.\u003c/p\u003e","slug":"michael-regan","email":"mregan@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[{"id":3748}]},"expertise":[{"id":32,"guid":"32.capabilities","index":0,"source":"capabilities"},{"id":75,"guid":"75.capabilities","index":1,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":2,"source":"capabilities"},{"id":20,"guid":"20.capabilities","index":3,"source":"capabilities"},{"id":102,"guid":"102.capabilities","index":4,"source":"capabilities"},{"id":131,"guid":"131.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Regan","nick_name":"Michael","clerkships":[],"first_name":"Michael","title_rank":9999,"updated_by":202,"law_schools":[{"id":722,"meta":{"degree":"J.D.","honors":"","is_law_school":"1","graduation_date":"2024-01-01 00:00:00"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":"Michael Regan is a lawyer of our Corporate Practice Group. Read more.","primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eMichael Regan is an associate in the Corporate practice group. He advises public and private companies, private equity firms and financial institutions on a variety of corporate matters, including mergers, acquisitions, investments and joint ventures.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":12285}]},"capability_group_id":1},"created_at":"2025-05-26T04:59:26.000Z","updated_at":"2025-05-26T04:59:26.000Z","searchable_text":"Regan{{ FIELD }}Michael Regan is an associate in the Corporate practice group. He advises public and private companies, private equity firms and financial institutions on a variety of corporate matters, including mergers, acquisitions, investments and joint ventures. Michael Regan lawyer Associate The University of Texas at Austin The University of Texas School of Law Fordham University Fordham University School of Law","searchable_name":"Michael Regan","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":427161,"version":1,"owner_type":"Person","owner_id":6415,"payload":{"bio":"\u003cp\u003eDylan is an associate in King \u0026amp; Spalding's Houston office and a member of the firm\u0026rsquo;s Finance \u0026amp; Restructuring practice group. Dylan\u0026rsquo;s practice focuses on representing\u0026nbsp;financial institutions,\u0026nbsp;sponsors and corporate borrowers with a wide range of financial transactions, including syndicated credit facilities, asset-based lending facilities, and acquisition finance. Dylan's practice also includes representing private equity firms and individual entities in buy- and sell-side private mergers and acquisitions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Dylan graduated cum laude from the University of Houston Law Center. While in law school, Dylan served as a member of the Houston Law Review and a member of the Energy and Environmental Law Society.\u003c/p\u003e","slug":"dylan-riola","email":"driola@kslaw.com","phone":null,"matters":null,"taggings":{"tags":[],"meta_tags":[]},"expertise":[{"id":75,"guid":"75.capabilities","index":0,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":1,"source":"capabilities"},{"id":29,"guid":"29.capabilities","index":2,"source":"capabilities"},{"id":10,"guid":"10.capabilities","index":3,"source":"capabilities"},{"id":32,"guid":"32.capabilities","index":4,"source":"capabilities"},{"id":33,"guid":"33.capabilities","index":5,"source":"capabilities"}],"is_active":true,"last_name":"Riola","nick_name":"Dylan","clerkships":[],"first_name":"Dylan","title_rank":9999,"updated_by":202,"law_schools":[{"id":2197,"meta":{"degree":"J.D.","honors":"cum laude","is_law_school":1,"graduation_date":"2022-01-01 00:00:00 UTC"},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":" ","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003eDylan is an associate in King \u0026amp; Spalding's Houston office and a member of the firm\u0026rsquo;s Finance \u0026amp; Restructuring practice group. Dylan\u0026rsquo;s practice focuses on representing\u0026nbsp;financial institutions,\u0026nbsp;sponsors and corporate borrowers with a wide range of financial transactions, including syndicated credit facilities, asset-based lending facilities, and acquisition finance. Dylan's practice also includes representing private equity firms and individual entities in buy- and sell-side private mergers and acquisitions.[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eBefore joining King \u0026amp; Spalding, Dylan graduated cum laude from the University of Houston Law Center. While in law school, Dylan served as a member of the Houston Law Review and a member of the Energy and Environmental Law Society.\u003c/p\u003e"},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10158}]},"capability_group_id":1},"created_at":"2025-05-26T04:58:59.000Z","updated_at":"2025-05-26T04:58:59.000Z","searchable_text":"Riola{{ FIELD }}Dylan is an associate in King \u0026amp; Spalding's Houston office and a member of the firm’s Finance \u0026amp; Restructuring practice group. Dylan’s practice focuses on representing financial institutions, sponsors and corporate borrowers with a wide range of financial transactions, including syndicated credit facilities, asset-based lending facilities, and acquisition finance. Dylan's practice also includes representing private equity firms and individual entities in buy- and sell-side private mergers and acquisitions.\nBefore joining King \u0026amp; Spalding, Dylan graduated cum laude from the University of Houston Law Center. While in law school, Dylan served as a member of the Houston Law Review and a member of the Energy and Environmental Law Society. Associate The University of Texas at Austin The University of Texas School of Law University of Houston University of Houston Law Center The University of Texas at Austin The University of Texas School of Law Texas","searchable_name":"Dylan Riola","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}